Skip to main content

Published locations for Idelalisib a favorable treatment option for pretreated relapsed or refractory CLL in the absence of alternatives

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Idelalisib a favorable treatment option for pretreated relapsed or refractory CLL in the absence of alternatives

User login

  • Reset your password
  • /content/idelalisib-favorable-treatment-option-pretreated-relapsed-or-refractory-cll-absence
  • /b-cell-lymphoma-icymi/article/264822/b-cell-lymphoma/idelalisib-favorable-treatment-option